Vimarsana
Biggest News Aggregation in the World

Page 19 - Roxana Mehran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roxana Mehran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roxana Mehran Today - Breaking & Trending Today

No-Pressure-Wire Physiology Boosts PCI Outcomes - Vimarsana News

No-Pressure-Wire Physiology Boosts PCI Outcomes

Chinese trial shows advantage over visual assessment alone

FFR Adds No Value to Angiography: RIPCORD 2 - Vimarsana News

FFR Adds No Value to Angiography: RIPCORD 2

In patients with coronary disease undergoing PCI, fractional flow reserve assessment at the time of angiography improves outcome but has no apparent value as a routine study in all CAD patients.

MASTER DAPT: 1 Month DAPT Enough After High-Bleeding-Risk PCI - Vimarsana News

MASTER DAPT: 1 Month DAPT Enough After High-Bleeding-Risk PCI

The study gives the first prospective randomized evidence for abbreviated dual antiplatelet therapy in this group of patients with high risk for bleeding.

Watchful Waiting Prevails for Most With Stable Angina - Vimarsana News

Watchful Waiting Prevails for Most With Stable Angina

email article Stable angina symptoms disappeared over time for many medically-treated patients without requiring medication changes or a revascularization procedure, according to CLARIFY registry data. Among patients who had stable coronary artery disease (CAD) and angina, 39.6% had symptoms resolve at 1 year without coronary revascularization. By 5 years, 45.8% of patients were alive, event-free, and angina-free, reported Philippe Gabriel Steg, MD, of Hôpital Bichat in Paris, and colleagues. The vast majority (84.4%) of individuals who had baseline angina controlled at 5-year follow-u...

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn't Boost 1-Year Outcomes - Vimarsana News

Use of a Rapid, High-Sensitivity Troponin Protocol Doesn't Boost 1-Year Outcomes

There were more downstream tests and some hints of harm, although one expert cautions this may have been chance.

Source: tctmd.com